MICA and breast cancer: However, LA-pulsed DCs pretreated with MICA/B monoclonal antibody could not significantly stimulate the secretion of these effectors by NK cells (Fig. 4e left, Additional file 1: Fig. S6a, b) and the cytotoxicity of NK cells against breast cancer cells (Fig. 4e right).